US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 23.860
  • +0.730+3.16%
Close Dec 20 16:00 ET
  • 23.860
  • 0.0000.00%
Post 16:20 ET
1.40BMarket Cap-15.91P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.96%-29.42M
-274.02%-62.25M
-61.86%-28.54M
-24.66%-99.91M
-71.09%-31.04M
-129.61%-34.6M
19.49%-16.64M
32.86%-17.63M
-49.20%-80.14M
5.85%-18.14M
Net income from continuing operations
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
Operating gains losses
----
----
----
--214.63M
--0
--25.06M
----
----
----
----
Depreciation and amortization
--0
--0
--0
-52.52%744K
-336.56%-220K
--0
-26.89%416K
35.98%548K
-0.57%1.57M
-77.37%93K
Other non cash items
216.85%18.58M
15,500.00%624K
21,400.00%430K
236.82%2.77M
3,854.03%18.66M
-4,540.50%-15.9M
103.88%4K
-97.92%2K
814.44%823K
291.87%472K
Change In working capital
230.18%10.35M
-588.21%-29.16M
354.62%3.47M
5.40%-5.21M
-60.88%-1.86M
-803.01%-7.95M
659.70%5.97M
69.06%-1.36M
-400.22%-5.5M
23.46%-1.16M
-Change in receivables
--0
--0
--0
-14.77%375K
-44.56%163K
880.53%1.48M
-346.90%-1.32M
122.84%45K
153.99%440K
136.07%294K
-Change in prepaid assets
5,762.07%3.28M
-358.85%-7.11M
-161.25%-381K
383.65%3.25M
-103.78%-65K
86.94%-58K
206.89%2.75M
314.67%622K
5.92%-1.14M
407.08%1.72M
-Change in payables and accrued expense
196.18%7.07M
-649.28%-22.05M
316.52%3.85M
-103.07%-7.08M
35.70%-1.96M
-509.36%-7.35M
221.89%4.01M
48.79%-1.78M
-603.47%-3.48M
-259.69%-3.05M
-Change in other current liabilities
--0
--0
--0
-434.71%-2.33M
--0
-4,214.89%-2.03M
23.66%-100K
-66.39%-198K
-7.67%-435K
-16.95%-138K
-Change in other working capital
----
----
----
165.34%575K
--0
--0
527.21%628K
93.09%-53K
-124.61%-880K
100.60%17K
Cash from discontinued investing activities
Operating cash flow
14.96%-29.42M
-274.02%-62.25M
-61.86%-28.54M
-24.66%-99.91M
-71.09%-31.04M
-129.61%-34.6M
19.49%-16.64M
32.86%-17.63M
-49.20%-80.14M
5.85%-18.14M
Investing cash flow
Cash flow from continuing investing activities
143.78%42.74M
-1,882.81%-120.52M
-691.34%-104.96M
-290.14%-108.39M
-351.94%-35.27M
-691.74%-97.63M
801.33%6.76M
-31.09%17.75M
352.04%57.01M
44.88%14M
Net PPE purchase and sale
--0
----
----
1,350.00%475K
--0
--0
----
----
93.37%-38K
--0
Net intangibles purchase and sale
----
----
----
--15M
--0
----
----
----
--0
--0
Net business purchase and sale
--0
----
----
--3.04M
--0
--0
----
----
--0
--0
Net investment purchase and sale
137.95%42.74M
-3,808.25%-120.52M
-691.34%-104.96M
-322.46%-126.9M
-351.94%-35.27M
-782.61%-112.63M
333.33%3.25M
-31.19%17.75M
358.76%57.05M
44.88%14M
Cash from discontinued investing activities
Investing cash flow
143.78%42.74M
-1,882.81%-120.52M
-691.34%-104.96M
-290.14%-108.39M
-351.94%-35.27M
-691.74%-97.63M
801.33%6.76M
-31.09%17.75M
352.04%57.01M
44.88%14M
Financing cash flow
Cash flow from continuing financing activities
201.99%12.78M
-99.83%360K
1,721,550.00%172.17M
746.05%361.08M
2,045,175.00%163.61M
-9,539.23%-12.53M
390.59%209.99M
-16.67%10K
2,963.75%42.68M
-110.00%-8K
Net issuance payments of debt
--0
--0
--0
96.17%-16K
--0
--0
95.43%-8K
95.35%-8K
18.04%-418K
95.27%-8K
Net common stock issuance
---157.31M
----
----
294.43%169.11M
--169.11M
--0
----
----
--42.87M
--0
Net preferred stock issuance
1,436.26%168.85M
-180.57%-169.21M
--169.21M
--197.36M
--0
---12.64M
--210M
--0
--0
--0
Proceeds from stock option exercised by employees
1,155.24%1.32M
--495K
24,288.89%4.39M
82.43%405K
--282K
176.32%105K
--0
-90.22%18K
-88.33%222K
--0
Net other financing activities
---78K
--0
---1.43M
---5.79M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
201.99%12.78M
-99.83%360K
1,721,550.00%172.17M
746.05%361.08M
2,045,175.00%163.61M
-9,539.23%-12.53M
390.59%209.99M
-16.67%10K
2,963.75%42.68M
-110.00%-8K
Net cash flow
Beginning cash position
-80.79%45.47M
523.40%227.87M
419.59%189.22M
114.46%36.42M
126.81%91.9M
502.63%236.68M
122.00%36.55M
114.46%36.42M
-81.53%16.98M
52.89%40.52M
Current changes in cash
118.03%26.1M
-191.15%-182.41M
30,582.54%38.66M
681.77%152.77M
2,445.66%97.3M
-11,226.75%-144.76M
774.56%200.11M
125.61%126K
126.08%19.54M
56.45%-4.15M
Effect of exchange rate changes
194.12%16K
--0
-136.36%-4K
123.58%25K
-60.87%18K
70.18%-17K
118.06%13K
147.83%11K
-606.67%-106K
1,433.33%46K
End cash Position
-22.11%71.58M
-80.79%45.47M
523.40%227.87M
419.59%189.22M
419.59%189.22M
126.81%91.9M
502.63%236.68M
122.00%36.55M
114.46%36.42M
114.46%36.42M
Free cash flow
14.96%-29.42M
-274.02%-62.25M
-61.86%-28.54M
-24.60%-99.91M
-71.09%-31.04M
-129.59%-34.6M
19.49%-16.64M
32.95%-17.63M
-47.69%-80.18M
5.85%-18.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.96%-29.42M-274.02%-62.25M-61.86%-28.54M-24.66%-99.91M-71.09%-31.04M-129.61%-34.6M19.49%-16.64M32.86%-17.63M-49.20%-80.14M5.85%-18.14M
Net income from continuing operations -72.11%-69.03M82.11%-38.84M-138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M
Operating gains losses --------------214.63M--0--25.06M----------------
Depreciation and amortization --0--0--0-52.52%744K-336.56%-220K--0-26.89%416K35.98%548K-0.57%1.57M-77.37%93K
Other non cash items 216.85%18.58M15,500.00%624K21,400.00%430K236.82%2.77M3,854.03%18.66M-4,540.50%-15.9M103.88%4K-97.92%2K814.44%823K291.87%472K
Change In working capital 230.18%10.35M-588.21%-29.16M354.62%3.47M5.40%-5.21M-60.88%-1.86M-803.01%-7.95M659.70%5.97M69.06%-1.36M-400.22%-5.5M23.46%-1.16M
-Change in receivables --0--0--0-14.77%375K-44.56%163K880.53%1.48M-346.90%-1.32M122.84%45K153.99%440K136.07%294K
-Change in prepaid assets 5,762.07%3.28M-358.85%-7.11M-161.25%-381K383.65%3.25M-103.78%-65K86.94%-58K206.89%2.75M314.67%622K5.92%-1.14M407.08%1.72M
-Change in payables and accrued expense 196.18%7.07M-649.28%-22.05M316.52%3.85M-103.07%-7.08M35.70%-1.96M-509.36%-7.35M221.89%4.01M48.79%-1.78M-603.47%-3.48M-259.69%-3.05M
-Change in other current liabilities --0--0--0-434.71%-2.33M--0-4,214.89%-2.03M23.66%-100K-66.39%-198K-7.67%-435K-16.95%-138K
-Change in other working capital ------------165.34%575K--0--0527.21%628K93.09%-53K-124.61%-880K100.60%17K
Cash from discontinued investing activities
Operating cash flow 14.96%-29.42M-274.02%-62.25M-61.86%-28.54M-24.66%-99.91M-71.09%-31.04M-129.61%-34.6M19.49%-16.64M32.86%-17.63M-49.20%-80.14M5.85%-18.14M
Investing cash flow
Cash flow from continuing investing activities 143.78%42.74M-1,882.81%-120.52M-691.34%-104.96M-290.14%-108.39M-351.94%-35.27M-691.74%-97.63M801.33%6.76M-31.09%17.75M352.04%57.01M44.88%14M
Net PPE purchase and sale --0--------1,350.00%475K--0--0--------93.37%-38K--0
Net intangibles purchase and sale --------------15M--0--------------0--0
Net business purchase and sale --0----------3.04M--0--0----------0--0
Net investment purchase and sale 137.95%42.74M-3,808.25%-120.52M-691.34%-104.96M-322.46%-126.9M-351.94%-35.27M-782.61%-112.63M333.33%3.25M-31.19%17.75M358.76%57.05M44.88%14M
Cash from discontinued investing activities
Investing cash flow 143.78%42.74M-1,882.81%-120.52M-691.34%-104.96M-290.14%-108.39M-351.94%-35.27M-691.74%-97.63M801.33%6.76M-31.09%17.75M352.04%57.01M44.88%14M
Financing cash flow
Cash flow from continuing financing activities 201.99%12.78M-99.83%360K1,721,550.00%172.17M746.05%361.08M2,045,175.00%163.61M-9,539.23%-12.53M390.59%209.99M-16.67%10K2,963.75%42.68M-110.00%-8K
Net issuance payments of debt --0--0--096.17%-16K--0--095.43%-8K95.35%-8K18.04%-418K95.27%-8K
Net common stock issuance ---157.31M--------294.43%169.11M--169.11M--0----------42.87M--0
Net preferred stock issuance 1,436.26%168.85M-180.57%-169.21M--169.21M--197.36M--0---12.64M--210M--0--0--0
Proceeds from stock option exercised by employees 1,155.24%1.32M--495K24,288.89%4.39M82.43%405K--282K176.32%105K--0-90.22%18K-88.33%222K--0
Net other financing activities ---78K--0---1.43M---5.79M------------------------
Cash from discontinued financing activities
Financing cash flow 201.99%12.78M-99.83%360K1,721,550.00%172.17M746.05%361.08M2,045,175.00%163.61M-9,539.23%-12.53M390.59%209.99M-16.67%10K2,963.75%42.68M-110.00%-8K
Net cash flow
Beginning cash position -80.79%45.47M523.40%227.87M419.59%189.22M114.46%36.42M126.81%91.9M502.63%236.68M122.00%36.55M114.46%36.42M-81.53%16.98M52.89%40.52M
Current changes in cash 118.03%26.1M-191.15%-182.41M30,582.54%38.66M681.77%152.77M2,445.66%97.3M-11,226.75%-144.76M774.56%200.11M125.61%126K126.08%19.54M56.45%-4.15M
Effect of exchange rate changes 194.12%16K--0-136.36%-4K123.58%25K-60.87%18K70.18%-17K118.06%13K147.83%11K-606.67%-106K1,433.33%46K
End cash Position -22.11%71.58M-80.79%45.47M523.40%227.87M419.59%189.22M419.59%189.22M126.81%91.9M502.63%236.68M122.00%36.55M114.46%36.42M114.46%36.42M
Free cash flow 14.96%-29.42M-274.02%-62.25M-61.86%-28.54M-24.60%-99.91M-71.09%-31.04M-129.59%-34.6M19.49%-16.64M32.95%-17.63M-47.69%-80.18M5.85%-18.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List